While the drug was approved by the FDA in September ... the upside was primarily driven by solid sales growth of asthma inhaler Trelegy Ellipta across all regions. The upside was partially offset ...

GSK plc GSK reported third-quarter 2024 core earnings of $1.27 per American depositary share (ADS), which beat the Zacks Consensus Estimate of $1.16. Core earnings declined 1% year over year on a ...

"As CMS continues to evolve its drug price negotiation programme ... for the evaluation of Breo Ellipta and Trelegy Ellipta – which made £1.1 billion (almost $1.5 billion) and £2.2 billion ...

Approved yesterday by the FDA, Trelegy Ellipta is the first ever daily single ... as the first Advair generic looks to be just around the corner, with the FDA already reviewing a challenger ...

first anti-IL5 drug, auto-injector device in India. It launched Trelegy Ellipta, the countrys first single inhaler triple therapy (SITT) for the maintenance treatment of chronic obstructive ...

Lupin is welcoming a new executive. Claus Jepsen is joining as president of global specialty. He brings over three decades of experience in commercial strategy, portfolio management and launch ...

After hours: October 31 at 7:59 PM EDT Loading Chart for DRUG ...

The Pharma Compliance Group is the go-to team for ensuring compliance with DEA regulations in the pharmaceutical industry (Manufacturing, Distribution, or Pharmacies). Companies have saved ...